There are no generic Fragmin (dalteparin) products available at this time. It is unclear why this is the case; there are no unexpired patents for Fragmin that would prevent the manufacturing of generic forms of this drug. It's important to note that dalteparin is the "generic name" for this product; it's not the same thing as a "generic version."
Can I Buy Generic Fragmin?
Fragmin® (dalteparin sodium) is a prescription medication used to treat and prevent blood clots in certain situations. It is also approved to prevent complications of certain heart-related "events" (such as heart attacks). Fragmin belongs to a group of medications known as low-molecular-weight heparins.
Fragmin is made by Pfizer, Inc., for Eisai, Inc. At this time, there are no generic versions of Fragmin.
When Will Generic Fragmin Be Available?
All of the patents for Fragmin have expired. However, there is no generic Fragmin available. Low-molecular-weight heparins are complicated drugs that are difficult and expensive to develop and produce. Perhaps no generic manufacturers have decided that it would be financially feasible to make a generic version of Fragmin yet.
As generic manufacturers become more sophisticated at producing complicated drugs, it may be possible that generic Fragmin will be available in the future. However, it is impossible to predict when exactly a generic version might become available.
Is Dalteparin a Generic Fragmin?
No -- dalteparin is the active ingredient in Fragmin, but it is not a generic version of it. What can be confusing is that oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine.
In order for there to be a generic version of a medicine, the original medicine must have gone off-patent, and another company besides the original manufacturer would make the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Fragmin [package insert]. Woodcliff Lake, NJ: Eisai, Inc.;2009 December.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 5, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click